, Tracking Stock Market Picks
Enter Symbol:
Arena Pharmaceuticals, Inc. (ARNA) [hlAlert]

down 50.18 %

Arena Pharmaceuticals, Inc. (ARNA) rated Buy with price target $6 by WallachBeth

Posted on: Tuesday,  May 12, 2015  10:25 AM ET by WallachBeth

WallachBeth rated Buy Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) on 05/12/2015. Previously WallachBeth rated Buy Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) on 11/15/2013.,
when the stock price was $5.32. Since then, Arena Pharmaceuticals, Inc. has lost 50.19% as of 10/08/2015's recent price of $2.65.
If you would have followed the previous WallachBeth's recommendation on ARNA, you would have lost 50.18% of your investment in 692 days.

Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory, and metabolic diseases. Arena's most advanced product candidate, lorcaserin, is being investigated in a Phase three clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/12/2015 10:25 AM Buy
4.26 6.00
as of 8/27/2015
1 Week down  -24.71 %
1 Month down  -40.84 %
3 Months down  -37.64 %
1 YTD down  -54.70 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/15/2013 8:25 AM Buy
5.32 9.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy